Wednesday
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Location: Grand Ballroom East, 3rd Floor
Moderators:Craig M. Walker, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Peter A. Schneider, MD  
SESSION 24 SCHEDULE
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes: Is Atherectomy Usage Overall Being Abused
  Presenter(s):Caitlin W. Hicks, MD, MS  
Location: Grand Ballroom East, 3rd Floor
7:59 AM - 8:04 AM Update On Atherectomy Devices: Do They Still Have A Role In 2024: Which One Or Ones Are Best: Has Their Benefit Been Proven
  Presenter(s):Todd R. Vogel, MD, MPH  
Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM Atherectomy In Patients With CLTI, In Stent Restenosis (ISR) And Diabetes: When Is It Helpful; How Durable Is It: Which Devices Are The Best
  Presenter(s):Ignacio Escotto, MD  
Location: Grand Ballroom East, 3rd Floor
8:11 AM - 8:16 AM The Objective Benefits Of Directional Atherectomy In Treating Lower Extremity Occlusive Lesions Are Real: When And How Should It Be Used And When Should It Not
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
8:17 AM - 8:22 AM What Is The Evidence That Atherectomy Is Effective In Femoropopliteal Interventions
  Presenter(s):Eric A. Secemsky, MD, MSc  
Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM 3-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And ISR: How Does It Work And Advantages
  Presenter(s):Michael K.W. Lichtenberg, MD  
Location: Grand Ballroom East, 3rd Floor
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS
8:29 AM - 8:34 AM Update And 2-Year Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent (DERS) With Plain Old Balloon Angioplasty (POBA): When Will DERSs Make A Difference
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD  
Location: Grand Ballroom East, 3rd Floor
8:35 AM - 8:40 AM Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results
  Presenter(s):Steven Kum, MD  
Location: Grand Ballroom East, 3rd Floor
8:41 AM - 8:46 AM Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short – Causing CLTI: What Are The Stents And When Do They Help: Why Will The DERSs Be Better
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
Location: Grand Ballroom East, 3rd Floor
8:47 AM - 8:52 AM Late-Breaking Final Patency And Wound Healing Results With A 3-French Compatible Microstent (From Micro Medical) Versus POBA For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD  
Location: Grand Ballroom East, 3rd Floor
8:53 AM - 9:00 AM Panel Discussion
END OF SESSION 24
previous next